Failure of dupilumab in a severe case of hidradenitis suppurativa

Ann Dermatol Venereol. 2023 Sep;150(3):241-242. doi: 10.1016/j.annder.2023.03.006. Epub 2023 May 22.

Author

Nicolas Kluger¹

Affiliation

¹ Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, 00250 Helsinki, Finland. Electronic address: nicolas.kluger@hus.fi.

PMID: 37225614
DOI: 10.1016/j.annder.2023.03.006

No abstract available

Keywords: Atopic dermatitis; Dupilumab; Hidradenitis suppurativa.

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Hidradenitis Suppurativa* / drug therapy
Humans

Substances

dupilumab
Antibodies, Monoclonal, Humanized